Announcements

Select Water Solutions, Inc. filed an 8-K on November 9, 2026, disclosing its financial and operating results for the quarter ended September 30, 2026, including record Water Infrastructure revenue and the completion of two strategic transactions.

Precision BioSciences, Inc. filed a Form 8-K on November 9, 2026, disclosing details of a public offering of common stock and pre-funded warrants entered into on November 5, 2026, along with the company's projected cash runway through the fourth quarter of 2029.

ProKidney Corp. filed a Form 8-K on November 9, 2026, disclosing its cash and cash equivalents and marketable securities position as of September 30, 2026, and announcing an updated investor presentation furnished under Regulation FD.

Via Transportation, Inc. filed its quarterly report on Form 10-Q with the SEC on November 9, 2026, covering the fiscal quarter ended September 30, 2026, and reporting condensed consolidated financial results for the period.

News Corporation filed a Form 8-K on November 9, 2026, reporting that it had provided its required daily share repurchase disclosures to the Australian Securities Exchange in connection with its previously announced $1 billion stock repurchase program, with the earliest event dated November 6, …

Pulmatrix, Inc. filed a Form 425 on November 9, 2026, disclosing that merger partner Eos SENOLYTIX, Inc. will present pre-clinical data on its lead compound PTC-2105 at the 19th Sarcopenia, Cachexia and Wasting Disorders International Conference on December 11, 2026, in Washington, D.C.

Adagene Inc. filed a Form 6-K on November 9, 2026, announcing the expected completion of the second closing of Sanofi's strategic investment following Adagene's achievement of Full Phase 2 Enrollment under the terms of the Securities Purchase Agreement dated June 30, 2025.